Ms. Shaheen is a director and founding member of the Anti-NMDA Receptor Encephalitis Foundation. Her daughter was the first positively identified case in Canada in January 2008. Since then, her daughter has had 4 relapses and continues to battle her way to recovery. She serves as Caregiver/Patient advocate on the Foundation. Ms. Shaheen holds an Honours B.A. in German Literature and Language from McGill University and a certificate in Publishing Studies from The Robert Gordon University, Aberdeen, Scotland. She has been an employee of the Department of Foreign Affairs, Trade and Development, Canada, since 1991. She is fluent in English, French and German.
Who We Are
Dr. Gregory Day
Board of Directors
Dr. Day completed his Neurology residency at the University of Toronto, before moving to Saint Louis (Missouri) to complete a post-doctoral fellowship in dementia. He is currently an Assistant Professor within the Department of Neurology at Washington University in St. Louis, and an Associate Director of the Knight Alzheimer Disease Research Center Clinical Core. His research focuses on characterizing the clinical presentation and improving treatments for patients with anti-NMDA-receptor encephalitis and related diseases, with an emphasis on improving long-term cognitive outcomes. Dr. Day is a founding member of the Anti-NMDA Receptor Encephalitis Foundation, and serves as the Clinical Director.
Dr. Harry E. Peery
Board of Directors
Dr. Peery holds a Masters degree in microbiology (Ohio State University), and a PhD in pharmacology (University of Saskatchewan). He is currently on a post-doctoral fellowship at the University of Calgary. In addition to his post-doctoral studies, his research interests are in the immunological pathogenesis of anti-NMDA receptor encephalitis and other neuroautoimmune disorders and in immunohistochemical detection of tumors. Dr. Peery is a director and founding member of the Anti-NMDA Receptor Encephalitis Foundation and serves as its Research Director.
Dr. Warren Foster
Board of Directors
Dr. Foster is a Professor in the Department of Obstetrics & Gynecology at McMaster University and an Adjunct Professor in the Department of Cellular Biology and Pharmacology at Florida International University. Professor Foster is an expert in reproductive biology and toxicology. His studies address human exposure to environmental contaminants including endocrine toxicants. Ongoing studies in his laboratory explore the cellular and molecular mechanisms underlying adverse reproductive health outcomes including dysregulation of ovarian function and endometriosis. He has served on numerous international and national expert advisory panels, editorial boards, as well as grant review committees. Dr. Foster is an editor for the Journal of Applied Toxicology and past President of the Canadian Fertility and Andrology Society. His research is supported by funding from the Canadian Institutes of Health Research (CIHR) and Health Canada. Dr. Foster is a founding director of the Foundation.
Andrew G. Burnett, CPA, CA
Mr. Burnett is an experienced Finance Professional who has worked in both the public accounting and industrial environment. He articled with Deloitte in Montreal and had several financial positions with Canadian Industries Limited (CIL) and Imperial Chemicals Limited (ICI) in North America. Prior to his retirement, some of Mr. Burnett’s responsibilities included Controller, CIL Corporation of America (Stamford, CT) and Chief Internal Auditor, ICI for North America (Toronto, ON, Wilmington, DE) Subsequently, Mr. Burnett worked in risk management at Canadian Tire Corporation in Toronto. During his career, he developed an understanding of not-for-profit organizations through his audit responsibilities with various charitable organizations and his involvement with other not-for-profit organizations.